Mahadevan, D., Morales, C., Cooke, L. S., Manziello, A., Mount, D. W., Persky, D. O., . . . Qi, W. (2014). Alisertib Added to Rituximab and Vincristine Is Synthetic Lethal and Potentially Curative in Mice with Aggressive DLBCL Co-Overexpressing MYC and BCL2. Public Library of Science.
Citación estilo ChicagoMahadevan, Daruka, Carla Morales, Laurence S. Cooke, Ann Manziello, David W. Mount, Daniel O. Persky, Richard I. Fisher, Thomas P. Miller, y Wenqing Qi. Alisertib Added to Rituximab and Vincristine Is Synthetic Lethal and Potentially Curative in Mice With Aggressive DLBCL Co-Overexpressing MYC and BCL2. Public Library of Science, 2014.
Cita MLAMahadevan, Daruka, et al. Alisertib Added to Rituximab and Vincristine Is Synthetic Lethal and Potentially Curative in Mice With Aggressive DLBCL Co-Overexpressing MYC and BCL2. Public Library of Science, 2014.